Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 USD | -.--% | -1.63% | -55.51% |
Chart calendar CEL-SCI Corporation
Upcoming events on CEL-SCI Corporation
Past events on CEL-SCI Corporation
16/05/2024 06:30 pm | Q2 2024 Earnings Release |
15/05/2024 | EF Hutton Investor Conference |
19/04/2024 | Annual General Meeting |
15/02/2024 06:30 pm | Q1 2024 Earnings Release |
22/12/2023 06:30 pm | Q4 2023 Earnings Release |
20/10/2023 | European Society for Medical Oncology Congress |
11/08/2023 05:30 pm | Q3 2023 Earnings Release |
08/07/2023 | American Head and Neck Cancer Society International Conference |
23/05/2023 07:30 pm | Annual General Meeting |
13/05/2023 | European Society for Radiotherapy and Oncology Congress |
13/05/2023 | Q2 2023 Earnings Release |
08/03/2023 | Head & Neck Oncology European Congress |
15/02/2023 07:30 pm | Q1 2023 Earnings Release |
28/12/2022 07:30 pm | FY 2022 Earnings Release |
10/09/2022 | European Society for Medical Oncology Congress |
15/08/2022 06:30 pm | Q3 2022 Earnings Release |
13/06/2022 07:30 pm | Annual General Meeting |
09/06/2022 02:00 am | LD Micro Invitational Conference |
06/06/2022 | American Society of Clinical Oncology Meeting - Abstract 6032 |
03/06/2022 | American Society of Clinical Oncology Meeting |
Annual results
Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,46 0,50 -7.45% | 0,56 0,60 -6.89% | 0,00 0,10 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -32,2 -31,8 -1.36% | -27,5 -26,7 -2.93% | -40,2 |
EBIT Million USD | Released Forecast Spread | -20,2 -17,9 -12.82% | -29,0 -24,2 -19.77% | -36,2 -32,8 -10.35% | -36,1 -34,1 -5.91% | -31,5 -31,2 -1.05% | -27,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,1 -21,0 -5.4% | -30,3 -28,9 -4.76% | -36,4 -34,0 -6.94% | -36,7 -35,7 -2.8% | -32,4 -31,9 -1.46% | -28,6 |
Net income Million USD | Released Forecast Spread | -22,1 -21,0 -5.4% | -30,3 -28,9 -4.76% | -36,4 -34,0 -6.94% | -37,6 -35,7 -5.41% | -32,4 -31,9 -1.46% | -28,6 |
EPS USD | Released Forecast Spread | -0,71 -0,64 -10.94% | -0,82 -0,77 -6.49% | -0,90 -0,79 -13.92% | -0,87 -0,83 -4.82% | -0,73 -0,71 -2.82% | -0,51 |
Announcement Date | 16/12/19 | 29/12/20 | 21/12/21 | 27/12/22 | 21/12/23 | - |
Quarterly results
Fiscal Period | Septiembre | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | |
EBITDA Million USD | Released Forecast Spread | -8,57 -3,60 -138.13% | -7,74 -7,00 -10.58% | -7,97 -7,50 -6.2% | -6,66 -7,90 15.67% | |||||||
EBIT Million USD | Released Forecast Spread | -9,55 -7,25 -31.75% | -8,72 -7,05 -23.68% | -8,95 -6,95 -28.75% | -7,65 -8,90 14.04% | -8,18 -7,50 -9.02% | -8,18 -7,65 -6.95% | -7,47 -7,50 0.43% | -13,6 -6,90 -96.55% | -7,20 | -7,00 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,82 -7,55 -30.11% | -9,63 -7,35 -31.06% | -8,46 -7,25 -16.72% | -7,85 -9,20 14.64% | -8,34 -7,60 -9.77% | -8,37 -7,70 -8.67% | -7,63 -7,70 0.9% | -14,0 -7,10 -96.54% | -7,40 | -7,20 | |
Net income Million USD | Released Forecast Spread | -9,82 -7,55 -30.11% | -9,93 -7,35 -35.06% | -9,10 -7,25 -25.47% | -8,03 -9,20 12.77% | -8,34 -7,60 -9.77% | -8,37 -7,70 -8.67% | -7,63 -7,70 0.9% | -6,71 | -14,0 -7,10 -96.54% | -7,40 | -7,20 |
EPS USD | Released Forecast Spread | -0,23 -0,18 -31.43% | -0,23 -0,17 -35.29% | -0,21 -0,17 -27.27% | -0,18 -0,21 14.29% | -0,19 -0,17 -11.76% | -0,19 -0,16 -18.75% | -0,16 -0,16 0% | -0,14 | -0,28 -0,14 -100% | -0,13 | -0,11 |
Announcement Date | 13/05/22 | 12/08/22 | 27/12/22 | 14/02/23 | 12/05/23 | 11/08/23 | 21/12/23 | 14/02/24 | 15/05/24 | - | - |
11/07/2024 11:30 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
16/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
23/07/2024 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 11:30 am | BIOGAIA AB: Q2 2024 Earnings Release |
24/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
25/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
25/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
25/07/2024 10:30 am | UCB: Q2 2024 Earnings Release |
26/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
30/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for CEL-SCI Corporation
23/05/2024 03:13 pm | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
14/05/2024 09:05 pm | GRIFOLS, S.A.: Q1 2024 Earnings Release |
13/05/2024 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
10/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
10/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
10/05/2024 01:35 am | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
10/05/2024 01:35 am | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
09/05/2024 12:00 pm | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
09/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
09/05/2024 01:46 am | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CVM Stock
- Calendar CEL-SCI Corporation